Generics - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 205 results

India revisits plans for free generic medicines, drug price fixing

India revisits plans for free generic medicines, drug price fixing

11-12-2014

Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing…

FinancialGenericsHealthcareIndiaPharmaceuticalPoliticsPricing

Teva issues 2015 business outlook short of expectations

Teva issues 2015 business outlook short of expectations

11-12-2014

Israel-based generics giant Teva Pharmaceutical Industries saw its shares gain 1.17% to $57.05, despite…

CopaxoneFinancialGenericsIsraelPulmicortTeva Pharmaceutcal Industries

Good results from Stada Arz, despite challenging conditions

13-11-2014

German drugmaker Stada Arzneimittel has posted financial results for the first nine months of 2014, showing…

Eastern EuropeFinancialGenericsRussiaSTADA Arzneimittel

Actavis third-qtr sales rocket, but loss posted

Actavis third-qtr sales rocket, but loss posted

05-11-2014

Ireland-headquartered generics drug major Actavis today reported net revenue leapt 83% to $3.7 billion…

ActavisFinancialGenerics

New analysis of potential savings from Biosimilars in USA

New analysis of potential savings from Biosimilars in USA

04-11-2014

Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such…

Anti-Arthritics/RheumaticsBiosimilarsFinancialGenericsOncologyRegulationSandozUSA

Mylan third-qtr beats expectations

Mylan third-qtr beats expectations

31-10-2014

US generics drugmaker Mylan reported third-quarter 2014 financial results that beat analysts’ consensus…

FinancialGenericsMylan

Dr Reddy’s reports higher sales but downturn in pretax profit

Dr Reddy’s reports higher sales but downturn in pretax profit

29-10-2014

Indian generics drugmaker Dr Reddy’s Laboratories today reported its unaudited consolidated financial…

Dr Reddy's LaboratoriesFinancialGenerics

Valeant third-qtr profits beat expectations

20-10-2014

Canadian drugmaker Valeant Pharmaceuticals International has posted third-quarter 2014 financial results…

AllerganFinancialGenericsMergers & AcquisitionsValeant Pharmaceuticals International

Netherlands Pharma market growth held back by govt generics policy

14-10-2014

The Netherlands’ pharmaceutical market value will rise slowly from around $6.7 billion in 2014 to $7.2…

FinancialGenericsHealthcareMarkets & MarketingNetherlands

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

02-09-2014

UK-based Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory…

EuropeEvohalerFinancialFluticasone PropionateGenericsGlaxoSmithKlineMylanProsonixRegulationRespiratory and Pulmonary

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

27-08-2014

Brazilian Minister of Health Arthur Chioro participated in the inauguration ceremony of NovaMed/EMS,…

BrazilEMS GroupFinancialGenericsNovaMedProduction

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Hikma's profits boosted in first half by good injectables sales

Hikma's profits boosted in first half by good injectables sales

20-08-2014

Revenue for Jordanian drugmaker Hikma Pharmaceuticals in the first half of 2014 rose 16% following a…

FinancialGenericsHikma PharmaceuticalsJordan

PHARMAC tender for generic medicines contributes NZ$38 million savings

PHARMAC tender for generic medicines contributes NZ$38 million savings

18-08-2014

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14…

Atypical antipsychoticsFinancialGenericsHealthcareNew Zealand

Despite difficult environment, Stada Arz posts solid results

Despite difficult environment, Stada Arz posts solid results

11-08-2014

German generic and branded drugmaker Stada Arzneimittel says that, in the first half of 2014, the group’s…

Business FinanceFinancialGenericsGermanyGermanySTADA Arzneimittel

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

Mylan’s 2nd-qtr earnings plunge on higher costs and product approval delays

07-08-2014

US generics major Mylan has reported that profits dropped nearly 30% in the second quarter of 2014, despite…

Business FinanceChief executiveFinancialFinancial ratiosFundamental analysisGenericsHeather BreschMylanUSA

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

31-07-2014

Israel’s Teva Pharmaceutical Industries, the world’s biggest generics drugmaker, reported disappointing…

CopaxoneFinancialGenericsIsraelTeva Pharmaceutical Industries

Dr Reddy’s achieves quarterly earnings growth of over 50%

Dr Reddy’s achieves quarterly earnings growth of over 50%

31-07-2014

Indian pharmaceutical company Dr Reddy’s has announced quarterly sales of 35.2 billion rupees.

Business FinanceDr Reddy's LaboratoriesFinancialFundamental analysisGenericsHealth Medical PharmaIndia

Ranbaxy down on same quarter last year following FDA fine

Ranbaxy down on same quarter last year following FDA fine

30-07-2014

Indian generic pharma company Ranbaxy, has reported consolidated sales of 23.7 billion rupees ($394 million),…

BSE SensexFinancialGenericsIndiaOver-the-counter accountingPharmaceutical industryRanbaxyRanbaxy Laboratories

Glenmark reports strong growth everywhere but the USA

Glenmark reports strong growth everywhere but the USA

25-07-2014

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20%…

FinancialGenericsGlenmark PharmaceuticalsIndia

South Africa’s NAPM calls for elimination of VAT on medicines

22-07-2014

South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed…

FinancialGenericsNational Association of Pharmaceutical ManufacturersPoliticsPricingSouth Africa

1 to 25 of 205 results

Back to top